Getting funding is getting harder and harder for healthcare startups. With FDA approval getting harder and more opaque and the future of insurance caught up in court battles, more and more VC firms are exiting the market. Today CNN Money's Term sheet profiled the problem http://finance.fortune.cnn.com/2011/11/28/pharma-startups-problem/?iid=HP_River.
Coinciding with that article was my latest Seeking Alpha article profiling Safeguard Scientifics (SFE), the venture investment strategies of big pharma, and a few ways for retail investors to get involved in this risky but potentially lucrative market. http://seekingalpha.com/article/310439-life-science-venture-capital-for-retail-investors